790 related articles for article (PubMed ID: 17001196)
21. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
Rousseau A; Boutolleau D; Titier K; Bourcier T; Chiquet C; Weber M; Colin J; Gueudry J; M'Garrech M; Bodaghi B; Burrel S; Agut H; Deback C; ; Labetoulle M
Antiviral Res; 2017 Oct; 146():205-212. PubMed ID: 28939476
[TBL] [Abstract][Full Text] [Related]
22. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
Gebhardt BM; Kaufman HE; Hill JM
Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
Higaki S; Watanabe K; Itahashi M; Shimomura Y
Curr Eye Res; 2009 Mar; 34(3):171-6. PubMed ID: 19274523
[TBL] [Abstract][Full Text] [Related]
25. A case of herpetic keratitis after intravitreal triamcinolone injection.
Gulkilik G; Demirci G; Ozdamar AM; Muftuoglu GI
Cornea; 2007 Sep; 26(8):1000-1. PubMed ID: 17721305
[TBL] [Abstract][Full Text] [Related]
26. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis.
Remeijer L; Maertzdorf J; Buitenwerf J; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):358-63. PubMed ID: 11818377
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of therapeutic activity of idoxuridine and acyclovir in experimentally-induced herpetic keratitis in rabbits (author's transl)].
Colin C; Chastel C; Quillien MC; Renard G
J Fr Ophtalmol; 1981; 4(1):33-43. PubMed ID: 7217623
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications.
Deai T; Fukuda M; Hibino T; Higaki S; Hayashi K; Shimomura Y
Cornea; 2004 Mar; 23(2):125-8. PubMed ID: 15075880
[TBL] [Abstract][Full Text] [Related]
29. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation.
Zhang W; Suzuki T; Shiraishi A; Shimamura I; Inoue Y; Ohashi Y
Cornea; 2007 Jan; 26(1):105-6. PubMed ID: 17198024
[TBL] [Abstract][Full Text] [Related]
30. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial.
van Rooij J; Rijneveld WJ; Remeijer L; Völker-Dieben HJ; Eggink CA; Geerards AJ; Mulder PG; Doornenbal P; Beekhuis WH
Ophthalmology; 2003 Oct; 110(10):1916-9; discussion 1919. PubMed ID: 14522763
[TBL] [Abstract][Full Text] [Related]
31. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice.
Benencia F; Courrèges MC; Gamba G; Cavalieri H; Massouh EJ
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1277-84. PubMed ID: 11328740
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B.
Blatt AN; Laycock KA; Brady RH; Traynor P; Krogstad DJ; Pepose JS
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3459-65. PubMed ID: 8225880
[TBL] [Abstract][Full Text] [Related]
33. Herpes Simplex DNA in Tears of Atypical Dendritic Keratitis and Multiple Punctate Subepithelial Stromal Opacity: A Case Report.
Hirota A; Inada N; Shiraki Y; Shoji J; Yamagami S
Cornea; 2020 Sep; 39(9):1177-1180. PubMed ID: 32073453
[TBL] [Abstract][Full Text] [Related]
34. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
[TBL] [Abstract][Full Text] [Related]
35. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
Tsatsos M; MacGregor C; Athanasiadis I; Moschos MM; Hossain P; Anderson D
Clin Exp Ophthalmol; 2016 Dec; 44(9):824-837. PubMed ID: 27273328
[TBL] [Abstract][Full Text] [Related]
36. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
37. Chronic recurrent varicella-zoster virus keratitis confirmed by polymerase chain reaction testing.
Magone MT; Nasser RE; Cevallos AV; Margolis TP
Am J Ophthalmol; 2005 Jun; 139(6):1135-6. PubMed ID: 15953460
[TBL] [Abstract][Full Text] [Related]
38. Bilateral herpes simplex keratitis presenting as peripheral ulcerative keratitis.
Praidou A; Androudi S; Kanonidou E; Konidaris V; Alexandridis A; Brazitikos P
Cornea; 2012 May; 31(5):570-1. PubMed ID: 22378116
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
Anand BS; Katragadda S; Mitra AK
J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
[TBL] [Abstract][Full Text] [Related]
40. Study of a polymerase chain reaction-based method for detection of herpes simplex virus type 1 DNA among Iranian patients with ocular herpetic keratitis infection.
Khodadoost MA; Sabahi F; Behroz MJ; Roustai MH; Saderi H; Amini-Bavil-Olyaee S; Arzenani MK
Jpn J Ophthalmol; 2004; 48(4):328-32. PubMed ID: 15295656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]